38.9842362, -77.0886204

4336 Montgomery Avenue,
Bethesda, MD, 20814, United States

India Globalization Capital Inc.

About Us

India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats.

IGC is developing a product portfolio of phytocannabinoid-based therapies through leading edge research for the treatment of a wide range of therapeutic indications. These include neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis, which are life altering or life threatening

IGC
India Globalization Capital Inc.
1.042
USD
0.038
(3.56%)